SAMC
Spectrum Asset Management (California) Portfolio holdings
AUM
$230M
This Quarter Return
+3.99%
1 Year Return
+18.85%
3 Year Return
+53.76%
5 Year Return
+87.53%
10 Year Return
+194.98%
AUM
$84.7M
AUM Growth
+$84.7M
(+6.2%)
Cap. Flow
+$3.86M
Cap. Flow
% of AUM
4.56%
Top 10 Holdings %
Top 10 Hldgs %
69.05%
Holding
55
New
7
Increased
18
Reduced
12
Closed
6
Top Buys
| 1 |
VanEck Gold Miners ETF
GDX
|
$3.95M |
| 2 |
Halliburton
HAL
|
$1.25M |
| 3 |
Core Laboratories
CLB
|
$1.2M |
| 4 |
Medtronic
MDT
|
$1.06M |
| 5 |
CVS Health
CVS
|
$906K |
Top Sells
| 1 |
L3Harris
LHX
|
$1.03M |
| 2 |
Equity Residential
EQR
|
$978K |
| 3 |
DXGE
WisdomTree Germany Hedged Equity Fund
DXGE
|
$965K |
| 4 |
Apple
AAPL
|
$965K |
| 5 |
NovaGold Resources
NG
|
$895K |
Sector Composition
| 1 | Healthcare | 6.92% |
| 2 | Energy | 4.69% |
| 3 | Technology | 2.46% |
| 4 | Consumer Staples | 2.44% |
| 5 | Communication Services | 2.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
SPDR S&P Dividend ETF
SDY
$20.6B
| $15.2M | 17.94% | 180,951 +378 | +0.2% | +$31.7K |
|
2
Invesco QQQ Trust
QQQ
$364B
| $8.72M | 10.3% | 81,081 -149 | -0.2% | -$16K |
|
|
BSCG
3
DELISTED
Guggenheim BulletShares 2016 Corporate Bond ETF
BSCG
| $7.63M | 9.02% | 346,341 -36,640 | -10% | -$808K |
|
4
Schwab US Large-Cap Growth ETF
SCHG
$47.9B
| $7.59M | 8.97% | 144,690 +4,142 | +3% | +$217K |
|
5
Vanguard Growth ETF
VUG
$185B
| $4.89M | 5.77% | 45,600 -75 | -0.2% | -$8.04K |
|
|
6
VanEck Gold Miners ETF
GDX
$19B
| $3.95M | 4.67% | +142,600 | New | +$3.95M |
|
7
iShares Europe ETF
IEV
$2.31B
| $3.43M | 4.05% | 90,793 +258 | +0.3% | +$9.75K |
|
8
Consumers Staples Select Sector SPDR Fund
XLP
$15.8B
| $2.92M | 3.45% | 52,961 +351 | +0.7% | +$19.4K |
|
9
Schwab Short-Term US Treasury ETF
SCHO
$11.7B
| $1.55M | 1.83% | 30,340 +1,575 | +5% | +$80.3K |
|
10
Microsoft
MSFT
$3.77T
| $1.43M | 1.69% | 28,020 +10 | +0% | +$512 |
|
11
Stryker
SYK
$150B
| $1.41M | 1.67% | 11,800 -85 | -0.7% | -$10.2K |
|
|
BCR
12
DELISTED
CR Bard Inc.
BCR
| $1.32M | 1.56% | 5,620 | – | – |
|
13
Novo Nordisk
NVO
$251B
| $1.3M | 1.54% | 24,200 -50 | -0.2% | -$2.69K |
|
|
14
Halliburton
HAL
$19.4B
| $1.25M | 1.48% | +27,690 | New | +$1.25M |
|
|
15
Core Laboratories
CLB
$540M
| $1.2M | 1.42% | +9,690 | New | +$1.2M |
|
16
Estee Lauder
EL
$33B
| $1.09M | 1.29% | 11,960 | – | – |
|
|
17
Medtronic
MDT
$119B
| $1.06M | 1.25% | +12,220 | New | +$1.06M |
|
18
Mastercard
MA
$538B
| $1.05M | 1.24% | 11,920 -200 | -2% | -$17.6K |
|
19
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$710M
| $1.03M | 1.22% | 6,855 +60 | +0.9% | +$9.05K |
|
20
Schwab US Broad Market ETF
SCHB
$36.2B
| $1.03M | 1.21% | 20,368 +6,419 | +46% | +$323K |
|
21
Walt Disney
DIS
$213B
| $947K | 1.12% | 9,678 -220 | -2% | -$21.5K |
|
|
22
CVS Health
CVS
$92.8B
| $906K | 1.07% | +9,465 | New | +$906K |
|
23
iShares S&P Mid-Cap 400 Growth ETF
IJK
$9.07B
| $905K | 1.07% | 5,350 +65 | +1% | +$11K |
|
24
Chevron
CVX
$324B
| $856K | 1.01% | 8,161 +180 | +2% | +$18.9K |
|
25
Exxon Mobil
XOM
$487B
| $662K | 0.78% | 7,066 +110 | +2% | +$10.3K |
|